大麻和大麻素在患有癌症的成年人中:ASCO指南
Ilana M Braun1, Kari Bohlke2, Donald I Abrams3
1Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
概括
在癌症患者中使用医用大麻超过了科学证据. 虽然它可能有助于化疗引起的恶心和吐,但在临床试验之外,不建议作为癌症治疗.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 基于证据的医学是基于证据的医学.
背景情况:
- 在癌症患者中,大麻和大麻素的使用正在增加.
- 对其在瘤学中的医学应用有必要提供基于证据的指导.
研究的目的:
- 引导临床医生,患者,护理人员和机构在癌症成年人中使用大麻和大麻素的医疗用途.
- 审查各种大麻和大麻素配方的疗效和安全性.
主要方法:
- 系统性审查,随机对照试验 (RCT) 和队列研究的系统性文献综述.
- 搜索了PubMed和Cochrane图书馆从创立到2023年1月的时间.
- 阿斯科专家小组召开会议,审查证据并提出建议.
主要成果:
- 证据基础包括13项系统性审查和5项初级研究 (4项RCT,1项队列研究).
- 对大多数结果的证据确定性是低或非常低.
结论:
- 在癌症患者中使用大麻和大麻素已经超过了科学证据.
- 建议不要使用大麻/大麻素作为针对癌症的治疗方法,除非是在临床试验中.
- 大麻/大麻素可以改善化疗引起的恶心和吐;其他支持性护理结果仍然不确定.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
277
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
277
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345


